NL2033865B1 - Method for detecting salmonella typhimurium by fluorescent probe based on nitrogen and sulfur co-doped graphene quantum dots - Google Patents
Method for detecting salmonella typhimurium by fluorescent probe based on nitrogen and sulfur co-doped graphene quantum dots Download PDFInfo
- Publication number
- NL2033865B1 NL2033865B1 NL2033865A NL2033865A NL2033865B1 NL 2033865 B1 NL2033865 B1 NL 2033865B1 NL 2033865 A NL2033865 A NL 2033865A NL 2033865 A NL2033865 A NL 2033865A NL 2033865 B1 NL2033865 B1 NL 2033865B1
- Authority
- NL
- Netherlands
- Prior art keywords
- solution
- detected
- quantum dots
- nitrogen
- salmonella typhimurium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/125—Sandwich assay format
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/149—Particles, e.g. beads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/519—Detection characterised by immobilisation to a surface characterised by the capture moiety being a single stranded oligonucleotide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Disclosed is a method for detecting Salmonella typhimurium by a fluorescent probe based on nitrogen and sulphur co-doped graphene quantum dots, belonging to the technical field of food safety. Based on the sandwich method strategy, the invention modifies streptavidin magnetic beads and nitrogen and sulphur co-doped graphene quantum dots with aptamers, using them as magnetic separation probes and signal probes, respectively; when the detected substance contains Salmonella typhimurium, the signal probe and the magnetic separation probe synchronously and specifically identify Salmonella typhimurium to form a sandwich structure. The sandwich structure is adsorbed by magnetic separation, and the supernatant is taken, and then its fluorescence intensity at 423 nm is measured to determine the concentration of Salmonella typhimurium in the detected solution. The method realizes synchronous identification of Salmonella typhimurium, is simple and convenient to operate, reduces the influence of sample matrix, has low cost, and has stable fluorescence characteristics; and as nitrogen and sulphur elements are doped in graphene quantum dots, the fluorescence quantum yield of graphene quantum dots is effectively improved, and the detection sensitivity is increased to 11.9 cfu/ml, so that the method has a good application and popularization prospect.
Description
METHOD FOR DETECTING SALMONELLA TYPHIMURIUM BY FLUORESCENT PROBE
BASED ON NITROGEN AND SULFUR CO-DOPED GRAPHENE QUANTUM DOTS
The invention belongs to the technical field of food safety, and in particular to a method for detecting Salmonella typhimurium by a fluorescent probe based on nitrogen and sulphur co- doped graphene quantum dots.
Salmonella typhimurium is one of the main pathogens causing acute gastroenteritis worldwide, and its infection symptoms usually include fever, nausea, vomiting and diarrhoea.
Ingesting contaminated dairy products, eggs, meat and poultry is the main way of infection.
Dairy products are a kind of food with rich nutrition and complex contents. However, because they contain protein, carbohydrates and fat, they not only provide important nutrition for human beings, but also provide living conditions for Salmonella typhimurium. Therefore, it is of great significance to establish a method for detecting Salmonella typhimurium in dairy products.
At present, Salmonella typhimurium is mainly detected by traditional detection technique, molecular biological technique and immunological detection technology. Traditional detection technology is regarded as the gold standard of pathogenic bacteria detection because of its high accuracy. However, the traditional culture method is complicated in operation, the detection period is about 5-7 days, and professionals are needed, which can't satisfy the rapid screening and risk detection of Salmonella typhimurium in dairy products. Molecular biological technique includes polymerase chain reaction (PCR), recombinase polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP) and rolling circle amplification (RCA), etc. which can't meet the needs of on-site detection due to the specific primer design, complicated nucleic acid amplification procedures and expensive instruments and equipment.
Immunological detection technology is mainly based on the rapid screening of antigen-antibody recognition technology, which has the advantages of simplicity, rapidness, high sensitivity, high throughput and high specificity. However, the quality of antibodies prepared in different batches is quite different, and the antibodies are expensive and their activity is easily affected by external factors, which limits their popularization and application.
In recent years, optical detection strategy has become the trend of rapid detection.
Traditional organic fluorescent dyes, such as carboxyfluorescein (FAM) and Rhodamine B, are widely used as signal markers in fluorescence detection strategies, but their further popularization is limited by poor fluorescence stability and narrow excitation spectrum.
Therefore, it is urgent to develop efficient and stable fluorescent nanoparticles. As a new nanomaterial, graphene quantum dots have excellent characteristics such as easy synthesis, stable fluorescence characteristics, broad-range light spectrum excitation and response, and good biocompatibility, and have achieved good results in many detection methods. Compared with graphene quantum dots, the doping of nitrogen and sulphur significantly changes the surface properties of graphene quantum dots, and further improves the absolute fluorescence quantum yield and photostability of graphene quantum dots.
The serious interference of milk matrix to the rapid detection strategy will significantly reduce the detection sensitivity and reliability. At present, although the pre-concentration of samples by centrifugation and the microfluidic method of adsorbing and decomposing interfering substances by embedding corresponding molecules in channels can reduce the interference of milk matrix, immunomagnetic separation technology is still the mainstream method to get rid of the interference of milk matrix because of its simple operation and high separation efficiency.
In addition, in view of the limitations of antibody, such as large quality differences between different batches during preparation, high price, and easy to be affected by external factors, aptamer, as a nucleic acid sequence that can specifically bind to the target substance, has successfully replaced antibody for specific and efficient recognition of the target substance due to its advantages of easy synthesis and labelling, low production cost, high stability, and strong specificity. Therefore, by modifying the magnetic beads on the aptamer as a means to get rid of the interference of milk matrix, and combining them with nitrogen and sulphur co-doped graphene quantum dots modified by aptamers with excellent luminescent properties and high- efficiency recognition characteristics, a new simple and highly sensitive technique for rapid detecting Salmonella typhimurium in milk matrix has been provided, and this technique has not been reported.
In order to realize simple, highly sensitive and rapid detection of Salmonella typhimurium in milk matrix, the invention provides a method for detecting Salmonella typhimurium by a fluorescent probe based on nitrogen and sulphur co-doped graphene quantum dots.
A method for detecting Salmonella typhimurium by a fluorescent probe based on nitrogen and sulphur co-doped graphene quantum dots: the signal probe solution is made of nitrogen and sulphur co-doped graphene quantum dots modified by the amino-functionalized aptamer (1); the DNA sequence of the amino- functionalized aptamer (1) is: 5'-NH2-(CH2)s-TAT GGC GGC GTC ACC CGA CGG GGA CTT
GAC ATT ATG ACA G-3' (SEQ ID NO: 1); the magnetic separation probe solution is made of streptavidin magnetic beads modified by the biotinylated aptamer (2); the DNA sequence of the biotinylated aptamer (2) is 5'-Biotin-GAG
GAA AGT CTA TAG CAG AGG AGA TGT GTG AAC CGA GTA A-3' (SEQ ID NO: 2); the standard curve: the abscissa X is the logarithmic value of Salmonella typhimurium concentration (cfu/ml), and the ordinate Y is lg-I, where lg is the fluorescence intensity at 423 nm when blank control solution is detected, and | is the fluorescence intensity at 423 nm when 102, 103, 10%, 105, 108 and 107 cfu/ml Salmonella typhimurium solutions are detected; the specific detection operation steps are as follows: (1) preparing of liquid to be detected taking 1 ml of liquid milk, centrifuging at 8000 x g for 5 min, discarding the supernatant, resuspending the precipitate with 1 ml of sterile PBS buffer with a concentration of 0.1 M and a pH of 7.4 to obtain the solution to be detected; (2) detecting (2.1) adding 100 HI signal probe solution and 36 pl magnetic separation probe solution into 500 pl solution to be detected, incubating at 37°C for 45 min to obtain the composite solution; (2.2) placing the composite solution on a magnetic frame for magnetic separation, and taking supernatant to obtain the solution to be detected; (2.3) putting the solution to be detected in a quartz colorimetric cuvette, setting the excitation wavelength of the F97Pro fluorescence spectrophotometer to 349 nm, and measuring the fluorescence intensity of the solution to be detected at 423 nm; (3) calculating the detected results substituting lo-I value into the standard curve, and calculating the concentration of
Salmonella typhimurium in the solution to be detected, that is, completing the detection; where
Io is the fluorescence intensity at 423 nm when the blank control solution is detected, and | is the fluorescence intensity at 423 nm when the solution to be detected is detected; when the lo-l value is greater than 104, it indicates that Salmonella typhimurium is detected in the detected substance; when the lg-l value is less than 104, it indicates that Salmonella typhimurium is not detected in the detected substance.
The further technical scheme is as follows:
The operation steps for preparing the signal probe solution are as follows: (1) adding 0.1 ml of nitrogen and sulphur co-doped graphene quantum dot stock solution into 9.9ml of ultrapure water to obtain 10 ml of nitrogen and sulphur co-doped graphene quantum dot aqueous solution; (2) adding 5 mg of N-hydroxysuccinimide and 10 mg of 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide hydrochloride into 10 ml of nitrogen and sulphur co-doped graphene quantum dot aqueous solution, adjusting the pH value to 5.0 with 10 mg/ml of sodium hydroxide (NaOH) solution, and incubating in the dark at room temperature for 30 min to obtain activated nitrogen and sulphur co-doped graphene quantum dot aqueous solution; (3) taking the activated nitrogen and sulphur co-doped graphene quantum dot aqueous solution, adjusting the pH value to 7.4 with 10 mg/ml sodium hydroxide (NaOH) solution, adding 20 pl of 100 uM amino-functionalized aptamer (1) solution, and suspending at room temperature for 2 h to obtain signal probe solution.
The operation steps for preparing the nitrogen and sulphur co-doped graphene quantum dot stock solution are as follows: (1) uniformly mixing 1.0 g citric acid with 0.3 g L-cysteine to obtain a reaction mixture; (2) heating the reaction mixture to 200°C in an oil bath pot to liquefy it, stopping heating when the colour of the reaction mixture liquid changes from light yellow to orange, and naturally cooling to room temperature to obtain an orange product; (3) dissolving the orange product in 100 ml of ultrapure water to obtain the nitrogen and sulphur co-doped graphene quantum dot stock solution.
The operation steps for preparing the magnetic separation probe solution are as follows: (1) taking 18 HI streptavidin magnetic beads with a concentration of 10 mg/ml in a siliconized centrifuge tube, adding 72 HI of 1 x B&W buffer solution, mixing them evenly, and putting them on the magnetic frame to stand for 1min, and discarding the supernatant after the streptavidin magnetic beads are fully adsorbed on the wall of the centrifuge tube; then, adding 72 ul of 1 x B&W buffer to repeat the above operation to obtain the treated streptavidin magnetic beads; (2) resuspending the treated streptavidin magnetic beads in 36 pl of 2 x B&W buffer, adding 36 pl of biotinylated aptamer (2) solution with a concentration of 1.5 uM, and incubating at room temperature for 30 min to obtain a coupling solution; (3) placing the coupling solution on the magnetic frame, standing for 1min, discarding the supernatant, adding 50 pl of 1% bovine serum albumin (BSA) solution, and incubating at room temperature for 30 min to obtain a closed coupling solution; (4) putting the closed coupling solution on the magnetic frame, standing for 1min, discarding the supernatant, and resuspending the precipitate in 36 ul of sterile PBS buffer with a concentration of 0.1 M and a pH value of 7.4 to obtain a magnetic separation probe solution.
The 1 x B&W buffer solution is obtained by diluting 2 x B&W buffer solution with equal volume of ultrapure water; the operation steps for preparing the 2 x B&W buffer solution are as follows: weighing 0.1211 g tris-(hydroxymethyl)-aminomethane (Tris}, 11.7 g sodium chloride (NaCl) and 0.03729 ethylenediaminetetraacetic acid (EDTA), adding deionized water, fully stirring and dissolving, adjusting the pH value to 7.5 with 36.5 mg/ml hydrochloric acid (HCI) solution, stirring evenly, fixing the volume to 100 ml, autoclaving at 121°C for 15 min, cooling to obtain 2 x B&W buffer, and storing in the refrigerator at 4°C for later use.
The detection and analysis principle of the method provided by the invention is as follows:
Based on the sandwich method strategy, nitrogen and sulphur co-doped graphene quantum dots modified by the amino-functionalized aptamer (1) are used as signal probes, and the biotinylated aptamer (2) is coupled to streptavidin magnetic beads to make magnetic separation probes. When the detected substance contains Salmonella typhimurium, the signal probe and the magnetic separation probe synchronously and specifically identify Salmonella typhimurium to form a sandwich structure. The sandwich structure is adsorbed by magnetic separation, and the supernatant is taken, and then its fluorescence intensity at 423 nm is measured to determine the concentration of Salmonella typhimurium in the detected solution.
Therefore, the content of signal probe in the supernatant of the sandwich structure removed by 5 magnetic separation decreases with the increase of Salmonella typhimurium concentration in the system. There is a linear relationship between the logarithmic value of Salmonella typhimurium concentration and the decrease value of fluorescence intensity of the system.
Therefore, a fluorescence probe based on nitrogen and sulphur co-doped graphene quantum dots is established to detect Salmonella typhimurium.
The beneficial technical effects of the invention are as follows: (1) Compared with traditional fluorescent compounds, such as organic dyes and polymers, the nitrogen and sulphur co-doped graphene quantum dots used in the method of the invention have more advantages, because graphene quantum dots have adjustable optical properties, high water solubility, high stability and organic inertness based on quantum confinement and edge effect. Nitrogen and sulphur co-doped graphene quantum dots are prepared by hydrothermal method with citric acid and L- cysteine as raw materials. Using cysteine in the synthesis process can homogenize the surface state of graphene quantum dots by doping heteroatoms and effectively improve the fluorescence quantum yield of graphene quantum dots. On the other hand, compared with most high-performance quantum dots, which are limited by the toxicity of metal elements (such as lead, cadmium and arsenic), graphene quantum dots have the advantages of low toxicity, good biocompatibility and metabolic degradation in biological applications. (2) According to the invention, immune magnetic beads formed by binding aptamers with magnetic beads are used to specifically identify and enrich Salmonella typhimurium in the sample matrix, so that the load of identifying molecules is effectively increased, the interference of milk matrix is reduced, and the detection sensitivity and reliability are improved. (3) The method of the invention uses aptamers instead of antibodies as identification originals, the detection cost is reduced by about 75%. Meanwhile, the synthetic raw materials of nitrogen and sulphur co-doped graphene quantum dots are low in price, high in yield and high in cost performance. (4) According to the invention, two different aptamers are respectively coupled on the nitrogen and sulphur co-doped graphene quantum dots and streptavidin magnetic beads, so that the defect that the same aptamer is used in other sandwich structures to compete for binding sites in target bacteria is avoided. (5) Based on the reverse detection strategy, the invention utilizes aptamer modified streptavidin magnetic beads and nitrogen and sulphur co-doped graphene quantum dots to specifically identify Salmonella typhimurium, and converts target substances into fluorescent signals to realize quantitative detection. In the traditional quantum dots-based immunosensor, the fluorescence signal of "magnetic bead-target substances-quantum dots" immunoconjugate is directly used as the detection reading. This detection method has two obvious problems.
Firstly, due to the blocking effect of magnetic beads, the fluorescence signal of quantum dots cannot be measured effectively. This is because the volume of magnetic beads is 6 orders of magnitude larger than that of quantum dots. When quantum dots are trapped on the surface of magnetic beads to form "magnetic beads-target substances-quantum dots" conjugates, quantum dots that are blocked in space cannot be excited, and the fluorescence signals of corresponding quantum dots are lost and cannot be measured, resulting in only a part of quantum dots being excited to generate fluorescence signals. Secondly, the "magnetic beads- target substances-quantum dots" immunoconjugate needs several washing and resuspension steps, which affects the speed and accuracy of the whole method. In order to solve these problems, the supernatant on the sandwich structure of "magnetic beads-target substances- quantum dots" removed by magnetic separation is used as the signal output in the reverse detection strategy, thus avoiding the interference of magnetic beads and complicated washing steps. Compared with the traditional quantum dots-based immunosensor, the sensitivity of the invention is improved by two orders of magnitude, the detection limit of Salmonella typhimurium is 11.9 cfu/ml, and the whole analysis process can be completed within 50 minutes. (6) According to the invention, the nitrogen and sulphur co-doped graphene quantum dots are combined with magnetic beads for the first time, and the rapid detection of Salmonella typhimurium in dairy products is realized through a sandwich method and a reverse detection strategy. Where, the nitrogen and sulphur co-doped graphene quantum dots in the sandwich structure have high fluorescence emission and photobleaching resistance, which can provide efficient and stable fluorescence signals for detection; immunomagnetic beads react specifically with Salmonella typhimurium, and the target substance is separated from the complex matrix under the action of external magnetic field, which can improve the detection sensitivity and reliability. In addition, the reverse detection strategy avoids the interference of magnetic beads on fluorescent signals and complicated washing steps, and improves the accuracy and speed of the invention.
FIG. 1 is a schematic diagram of the detection method of the present invention;
FIG. 2 is a fluorescence spectrum of Salmonella typhimurium with different concentrations in
Example 2 of the present invention;
FIG. 3 is a standard curve diagram of concentration logarithm of Salmonella typhimurium and fluorescence intensity drawn in Example 2 of the present invention;
FIG. 4 is a specificity diagram of the detection method in Example 4 of the present invention.
The following examples will further illustrate the present invention, but not limit the present invention.
Unless otherwise defined, the technical and scientific terms used in the following examples have the same meanings as commonly understood by those skilled in the art to which this invention belongs.
The test reagent consumables used in the following examples, unless otherwise specified, are conventional biochemical reagents; unless otherwise specified, the experimental methods are conventional. For the quantitative experiments in the following examples, three repeated experiments are set, and the results are averaged; % in the following examples, unless otherwise specified, are percentages by mass.
In the following examples, streptavidin magnetic beads and the magnetic frame are purchased from Beyotime Biotech. Inc. (Beyotime); citric acid, L-cysteine, bovine serum albumin, PBS buffer with a concentration of 0.1 M and pH value of 7.4 and amino- functionalized/biotinylated nucleic acid aptamer are purchased from Sangon Biotech (Shanghai)
Co., Ltd.; N-hydroxysuccinimide and 1-(3- dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride are purchased from Sigma-Aldrich, Inc., United States.
Example 1
The preparations of nitrogen and sulphur co-doped graphene quantum dot stock solution, signal probe solution and magnetic separation probe solution used in the detection method of the invention. (1) The operation steps for preparing the nitrogen and sulphur co-doped graphene quantum dot stock solution are as follows: (1.1) uniformly mixing 1.0 g citric acid with 0.3 g L-cysteine to obtain a reaction mixture; (1.2) heating the reaction mixture to 200°C in an oil bath pot to liquefy it, stopping heating when the colour of the reaction mixture liquid changes from light yellow to orange, and naturally cooling to room temperature to obtain an orange product; (1.3) dissolving the orange product in 100 ml of ultrapure water to obtain the nitrogen and sulphur co-doped graphene quantum dot stock solution. (2) The operation steps for preparing the signal probe solution are as follows: (2.1) adding 0.1 ml of nitrogen and sulphur co-doped graphene quantum dot stock solution into 9.9ml of ultrapure water to obtain 10 ml of nitrogen and sulphur co-doped graphene quantum dot aqueous solution; (2.2) adding 5 mg of N-hydroxysuccinimide and 10 mg of 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide hydrochloride into 10 ml of nitrogen and sulphur co-doped graphene quantum dot aqueous solution, adjusting the pH value to 5.0 with 10 mg/ml of sodium hydroxide (NaOH)
solution, and incubating in the dark at room temperature for 30 min to obtain activated nitrogen and sulphur co-doped graphene quantum dot aqueous solution;
(2.3) taking the activated nitrogen and sulphur co-doped graphene quantum dot aqueous solution, adjusting the pH value to 7.4 with 10 mg/ml sodium hydroxide (NaOH) solution, adding
20 plof 100 uM amino-functionalized aptamer (1) solution, and suspending at room temperature for 2 h to obtain signal probe solution;
the DNA sequence of the amino-functionalized aptamer (1) is:
5'-NH2-(CH2)s-TAT GGC GGC GTC ACC CGA CGG GGA CTT GAC ATT ATG ACA G-3'
(SEQ ID NO: 1).
(3) The operation steps for preparing the magnetic separation probe solution are as follows:
(3.1) taking 18 pl streptavidin magnetic beads with a concentration of 10 mg/ml in a siliconized centrifuge tube, adding 72 ul of 1 x B&W buffer solution, mixing them evenly, and putting them on the magnetic frame to stand for 1min, and discarding the supernatant after the streptavidin magnetic beads are fully adsorbed on the wall of the centrifuge tube; then, adding
72 Jl of 1 x B&W buffer to repeat the above operation to obtain the treated streptavidin magnetic beads;
the 1 x B&W buffer solution is obtained by diluting 2 x B&W buffer solution with equal volume of ultrapure water;
the operation steps for preparing the 2 x B&W buffer solution are as follows:
weighing 0.1211 g tris-(hydroxymethyl)-aminomethane (Tris}, 11.7 g sodium chloride (NaCl) and 0.0372 g ethylenediaminetetraacetic acid (EDTA), adding deionized water, fully stirring and dissolving, adjusting the pH value to 7.5 with 36.5 mg/ml hydrochloric acid (HCI) solution, stirring evenly, fixing the volume to 100 ml, autoclaving at 121°C for 15 min, cooling to obtain 2 x B&W buffer, and storing in the refrigerator at 4°C for later use;
(3.2) resuspending the treated streptavidin magnetic beads in 36 pl of 2 x B&W buffer, adding 36 pl of biotinylated aptamer (2) solution with a concentration of 1.5 uM, and incubating at room temperature for 30 min to obtain a coupling solution;
the DNA sequence of the biotinylated aptamer (2) is
5'-Biotin-GAG GAA AGT CTA TAG CAG AGG AGA TGT GTG AAC CGA GTA A-3'
(SEQ ID NO: 2);
(3.3) placing the coupling solution on the magnetic frame, standing for 1min, discarding the supernatant, adding 50 pl of 1% bovine serum albumin (BSA) solution, and incubating at room temperature for 30 min to obtain a closed coupling solution;
(3.4) putting the closed coupling solution on the magnetic frame, standing for 1min,
discarding the supernatant, and resuspending the precipitate in 36 ul of sterile PBS buffer with a concentration of 0.1 M and a pH value of 7.4 to obtain a magnetic separation probe solution.
Example 2
Establishment of detection equation
Referring to FIG. 1, the specific detection operation steps are as follows: (1) taking 1 ml of Salmonella typhimurium stock solution cultured in LB broth for 12 h to the late logarithmic growth stage, transferring it into a sterilized centrifuge tube, centrifuging at 8000 x g for 5 min, discarding the supernatant, and resuspending in 1 ml of sterile PBS buffer with concentration of 0.1 M and pH value of 7.4 to obtain bacterial suspension; diluting the bacteria suspension with sterile PBS buffer with the concentration of 0.1 M and pH value of 7.4, and preparing the Salmonella typhimurium solutions with the concentrations of 102, 10%, 10%, 105, 108, 107 cfu/ml; in addition, taking sterile PBS buffer with a concentration of 0.1 M and a pH value of 7.4 as a blank control solution, and the concentration of Salmonella typhimurium in the blank control solution is 0 cfu/ml; (2) adding the same 100 pl signal probe solution and 36 ul magnetic separation probe solution to 500 pl blank control solution and Salmonella typhimurium solution with concentrations of 102, 103, 10%, 105, 10°, 107 cfu/ml, and incubating at 37°C for 45 min to obtain seven composite solutions; the signal probe solution is prepared by Example 1; the magnetic separation probe solution is prepared by Example 1; (3) placing the seven composite solutions on a magnetic frame for magnetic separation, and taking supernatant to obtain the corresponding seven solutions to be detected; (4) taking seven solutions to be detected in quartz colorimetric cuvettes, and setting the excitation wavelength of F97Pro fluorescence spectrophotometer to 349 nm, the excitation broadband to 10nm, the emission broadband to 10nm, and the detection range of emission wavelength to 370-600nm; determining the fluorescence intensity at 423 nm of seven solutions to be detected with Salmonella typhimurium concentrations of 0, 102, 103, 10%, 105, 108, 107 cfu/ml, the results are shown in FIG. 2; taking lo-l as the ordinate Y, and the logarithmic value of
Salmonella typhimurium concentration (cfu/ml) as the abscissa X to draw the standard curve, the results are shown in FIG. 3, and the detection equation is obtained: Y = 378.30X - 302.45, the correlation coefficient is 0.9976, and the detection limit is 11.9 cfu/ml;
Io is the fluorescence intensity at 423 nm when blank control solution is detected, and | is the fluorescence intensity at 423 nm when Salmonella typhimurium solutions with the concentrations of 10%, 103, 10%, 105, 108, 107 cfu/ml are detected.
Example 3
Detection of Salmonella typhimurium in artificially contaminated milk (1) Preparation of liquid to be detected of artificially contaminated milk
Inoculating Salmonella typhimurium solution with unknown concentration in 1 ml sterile milk, centrifuging at 8000 x g for 5 min, discarding the supernatant, resuspending the precipitate with 1 ml of sterile PBS buffer with a concentration of 0.1 M and a pH of 7.4 to obtain the milk solution to be detected; (2) Sample determination (2.1) adding 100 HI signal probe solution and 36 pl magnetic separation probe solution into 500 ul milk solution to be detected, incubating at 37°C for 45 min to obtain the composite solution; the signal probe solution is prepared by Example 1; the magnetic separation probe solution is prepared by Example 1; (2.2) placing the composite solution on a magnetic frame for magnetic separation, and taking supernatant to obtain the solution to be detected; (2.3) putting the solution to be detected in a quartz colorimetric cuvette, setting the excitation wavelength of the F97Pro fluorescence spectrophotometer to 349 nm, and measuring the fluorescence intensity of the solution to be detected at 423 nm; (3) Calculating the detected results (3.1) calculating the test result according to the test equation, the detection equation is: Y = 378.30X - 302.45, where X represents the logarithmic value of Salmonella typhimurium concentration, and Y is lo-I; where lg is the fluorescence intensity at 423 nm when the blank control solution is detected, and | is the fluorescence intensity at 423 nm when the solution to be detected is detected; the detection equation is obtained by Example 2; the fluorescence intensity lo of the blank control solution at 423 nm is measured by
Example 2; (3.2) the calculated lo-1 value is 1026.13, which indicates that Salmonella typhimurium is detected in artificially contaminated milk; by substituting the lo-I value into the detection equation, the concentration of Salmonella typhimurium is 3.25 x 103 cfu/ml; when the lo-I value is greater than 104, it indicates that Salmonella typhimurium is detected in the detected substance.
Example 4
Specific detection method of Salmonella typhimurium in milk (1) Sample processing
Placing the same 1 ml sterile milk samples in seven sterile centrifuge tubes, and adding 1 ml of Salmonella typhimurium, Listeria monocytogenes, Pseudomonas aeruginosa, Escherichia coli, Enterobacter sakazakii, Staphylococcus aureus and Vibrio parahaemolyticus with the concentration of 10° cfu/ml into the seven centrifuge tubes to obtain seven mixed solutions; centrifuging the seven mixed solutions at 8000 x g for 5 min, discarding the supernatant, resuspending the precipitate with 1 ml sterile PBS buffer with the concentration of 0.1 M and pH value of 7.4 to obtain seven dairy products to be detected containing different pathogenic bacteria; (2) Detection (2.1) adding 500 pl of corresponding dairy products to be detected containing different pathogenic bacteria into seven sterile centrifuge tubes, adding 100 pl of signal probe solution and 36 pl of magnetic separation probe solution, and incubating at 37°C for 45 min to obtain seven composite solutions; the signal probe solution is prepared by Example 1; the magnetic separation probe solution is prepared by Example 1; (2.2) placing the seven composite solutions on a magnetic frame for magnetic separation, and taking supernatant to obtain the corresponding seven solutions to be detected; (2.3) taking seven solutions to be detected in quartz colorimetric cuvettes, and setting the excitation wavelength of F97Pro fluorescence spectrophotometer to 349 nm, and measuring the fluorescence intensity of seven solutions to be detected at 423 nm; (3) Result analysis (3.1) calculating the test result according to the test equation, the detection equation is: Y = 378.30X - 302.45, where X represents the logarithmic value of Salmonella typhimurium concentration, and Y is lo-I; where lg is the fluorescence intensity at 423 nm when the blank control solution is detected, and | is the fluorescence intensity at 423 nm when the solution to be detected is detected; the detection equation is obtained by Example 2; the fluorescence intensity ls of the blank control solution at 423 nm is measured by
Example 2; (3.2) results as shown in FIG. 4, due to the specific recognition of Salmonella typhimurium by aptamers, when Salmonella typhimurium exists in the system, the fluorescence intensity of the solution to be detected at 423 nm is obviously weaker than that of the blank control solution, and the lg-l value is 1958; when Salmonella typhimurium does not exist in the system, the fluorescence intensities of the solution to be detected of Listeria monocytogenes, Pseudomonas aeruginosa, Escherichia coli, Enterobacter sakazakii, Staphylococcus aureus and Vibrio parahaemolyticus at 423 nm have no obvious change compared with the blank control solution, and the corresponding lg-l values are 59, 43, 58, 49, 52 and 43, respectively, which shows that the invention has good specificity for Salmonella typhimurium; when the lo-I value is greater than 104, it indicates that Salmonella typhimurium is detected in the detected substance; when the ls-l value is less than 104, it indicates that Salmonella typhimurium is not detected in the detected substance.
Example 5
Application of the invention in detecting the content of Salmonella typhimurium in milk
(1) Sample processing
Taking 1 ml of commercially available milk, centrifuging at 8000 x g for 5 min, discarding the supernatant, resuspending the precipitate with 1 ml of sterile PBS buffer with a concentration of 0.1 M and a pH of 7.4 to obtain the solution to be detected; (2) Detection (2.1) adding 100 HI signal probe solution and 36 pl magnetic separation probe solution into 500 pl solution to be detected, incubating at 37°C for 45 min to obtain the composite solution; the signal probe solution is prepared by Example 1; the magnetic separation probe solution is prepared by Example 1; (2.2) placing the composite solution on a magnetic frame for magnetic separation, and taking supernatant to obtain the solution to be detected; (2.3) putting the solution to be detected in a quartz colorimetric cuvette, setting the excitation wavelength of the F97Pro fluorescence spectrophotometer to 349 nm, and measuring the fluorescence intensity of the solution to be detected at 423 nm; (3) Result analysis (3.1) calculating the test result according to the test equation, the detection equation is: Y = 378.30X - 302.45, where X represents the logarithmic value of Salmonella typhimurium concentration, and Y is lo-I; where lg is the fluorescence intensity at 423 nm when the blank control solution is detected, and | is the fluorescence intensity at 423 nm when the solution to be detected is detected; the detection equation is obtained by Example 2; the fluorescence intensity ls of the blank control solution at 423 nm is measured by
Example 2; (3.2) compared with the blank control solution, the fluorescence intensity | of the solution to be detected at 423 nm hardly changes, and the Is-I value is 12, which indicates that Salmonella typhimurium has not been detected in milk; when the lo-l value is less than 104, it indicates that Sa/monella typhimurium is not detected in the detected substance.
The embodiments of the present invention have been described in detail above, but the foregoing contents are only embodiments of the present invention and are not intended to limit the present invention. Any modification, equivalent substitution and improvement made within the scope of application of the present invention shall be included in the scope of protection of the present invention.
i xml versicn=Nl, ON encoding=TUTFE-8" 7 2 <!DOCTYPE ST26SequenceListing PUBLIC "-//WIPO//DTD Sequence Listing 1.3//EN" "ST265equenceListing V1 3.dtd"> 3 <ST26Sequencelisting drdversion="NVL 3% filshName="segumoce. amln soilwareNeamc="WIPO
Saguanae” zoftwarevVercsicn=Mg, 1.17 productionDate="2022~13-287%>
A <Applicatioconidentiiflcatlon> <IPOfficeCode>NL</IPOfficelode> & <ApplicationNumerTezt></ApplicetionNumberText»> 7 <FiliogDate></FilingDaLter 8 </Ppplicationidentification> 3 <“ApplicentFileReference)» Salmonella NL</AppiicantFileReference> <BarliiestPricritvipplicationidentification> il <IPOfEiceloderCN</TIPOfflceloderx 12 <ApplicationNumberText>202210857738.4</ApplicaticnlunberText> 13 <“FilingDate>2022-07-21</FilingZDete> 14 </FarliestPriorityApplicationidentification> in <ApplicaniNeme languagelode="an">Hefeli University of Technology /ApplicantNems> is <iovertliontitie lsngugeloge="en"òMETHOD FOR DETECTING SALMONELLA TYPHIMURIUM BY
FLUORESCENT PROBE BASED ON NITROGEN AND SULFUR CO-DOPED GRAPHENE QUANTUM
DOTS</inventionTitie>
Lj <SequencaTotalQuantity»2</SeguencaTotal Quantity <SequenceData sequenceIDNumber="iN>
Le <INSDSeqr “0 <INSDSeq length>40</INSD5eq length» zl <INSDSeq moltype>DNA</INSDSeg moltype> 27 <INSDSeq divislion»PAT</INSDSeqg division» 22 <INSDSeg feature~tablex 24 <INSDFsature> <IN3DFeature key>source</IN3DFeature key> 28 <IN3DFeature location>l..40</INSDFeaturs locations 27 <INSDFsature qualsg> 23 <INSDuuelifier> “4 <INSDoualifier name>mol type“ /INSDQualifier name>
Zl <INSDQualifisr value>other DNA</INSDQualifier valuer 21 </INSDOualifier> 22 <INSDOualifier id="gir> an <IN3DQualifier name>organism</INSDQualifisr name> 34 <INSDQualifier valuersynthetic construct</INSDQualifier valued </INSDOualifier> 36 </THSDFeaturs guals> a7 </INSDFeature> 28 </IN3DSeqg feature-table> <IN3DSeq seguencertatggeggegtcacccgacggggacttgacattatgacag“/INSDSeq sequen cE </INSDSeg> 41 </SequenceData> 4% <SequernceData sequenceliNutec=M4"> 43 <INSDSeqg> 44 <INSDSeq length>40</INSDSeq length> 35 <INSDSeq moltype>DNA-/INSDSeg moltype> 48 ZINSDSeq division>PAT</INSDSeq division» 4% <INSDSeq feabure-table> <INSDreature> 4% <INSDFeature key>source</INSDFeature key>
SO <INSDFeature location>l..40</INSDFeature locations
Si <INSDFealurse guals> 52 <INSDOQualifier» 52 <IN3DQualifier namedmol type</INSDQualifisr name> 54 <INSDUvaelifier valuerother DNA</INSDGualifier value> </INSDOuali fier» u
LE <INSDQuaiifler id="g2">
Lj <INSDQualifier namerorganism</INSDQualifier name>
Ld <INSDQualiflsr value>synthetic construct /INSDQualifier value> 53 </INSDOualifier> a0 </IN3DFeature guala> al </INSDFealure> u el </INSDSeo featurs-table> €3 7 <INSDSeg sequencergaggaaagtctatagcagaggagatgtgtgaaccgagtaa-/INSD3eq sequen ce sd </INSDSeg> a5 </Seguencedata> 58 <{5ST26SequenceListing> 47
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210857738.4A CN115236050B (en) | 2022-07-21 | 2022-07-21 | Method for detecting salmonella typhimurium by using fluorescent probe based on nitrogen-sulfur co-doped graphene quantum dots |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2033865B1 true NL2033865B1 (en) | 2023-06-28 |
Family
ID=83673940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2033865A NL2033865B1 (en) | 2022-07-21 | 2022-12-29 | Method for detecting salmonella typhimurium by fluorescent probe based on nitrogen and sulfur co-doped graphene quantum dots |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115236050B (en) |
NL (1) | NL2033865B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109596827A (en) * | 2019-01-17 | 2019-04-09 | 长江师范学院 | Fluorescence detection test strip and its preparation method and application that is a kind of while detecting 4 kinds of pathogenic bacteria |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105861295A (en) * | 2016-05-24 | 2016-08-17 | 长沙医学院 | Biosensor for detecting salmonella typhimurium and preparation and detection methods |
SG11201908594VA (en) * | 2017-03-28 | 2019-10-30 | Agency Science Tech & Res | Nanomaterial-based bacterial sensors |
CN107505306A (en) * | 2017-08-10 | 2017-12-22 | 江南大学 | The method of salmonella in Raman spectrum quick detection milk based on heavy water mark |
CN111638330B (en) * | 2020-06-10 | 2021-04-02 | 青岛农业大学 | Biosensor for detecting salmonella typhimurium and application thereof |
CN113912123B (en) * | 2021-09-23 | 2023-07-28 | 山东师范大学 | Salmonella typhimurium multimode test strip based on magnetic molybdenum disulfide catalysis and photo-thermal effect, and detection method and application thereof |
-
2022
- 2022-07-21 CN CN202210857738.4A patent/CN115236050B/en active Active
- 2022-12-29 NL NL2033865A patent/NL2033865B1/en active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109596827A (en) * | 2019-01-17 | 2019-04-09 | 长江师范学院 | Fluorescence detection test strip and its preparation method and application that is a kind of while detecting 4 kinds of pathogenic bacteria |
Non-Patent Citations (1)
Title |
---|
WANG RENJIE ET AL: "Rapid and sensitive detection of Salmonella typhimurium using aptamer-conjugated carbon dots as fluorescence probe", ANALYTICAL METHODS, vol. 7, no. 5, 1 January 2015 (2015-01-01), GB, pages 1701 - 1706, XP093051486, ISSN: 1759-9660, Retrieved from the Internet <URL:https://pubs.rsc.org/en/content/articlepdf/2015/ay/c4ay02880e> DOI: 10.1039/C4AY02880E * |
Also Published As
Publication number | Publication date |
---|---|
CN115236050A (en) | 2022-10-25 |
CN115236050B (en) | 2024-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bu et al. | Ultra technically-simple and sensitive detection for Salmonella enteritidis by immunochromatographic assay based on gold growth | |
Xu et al. | In-field detection of multiple pathogenic bacteria in food products using a portable fluorescent biosensing system | |
Hibi et al. | Combination of immunomagnetic separation with flow cytometry for detection of Listeria monocytogenes | |
CN109207567B (en) | Method for determining staphylococcus aureus based on aptamer and strand displacement amplification reaction | |
Wang et al. | Sensitive detection of Salmonella with fluorescent bioconjugated nanoparticles probe | |
CN108680545B (en) | On-site rapid detection method for food-borne pathogenic bacteria | |
Boyacı et al. | Amperometric determination of live Escherichia coli using antibody-coated paramagnetic beads | |
CN108300758B (en) | Hemin hybrid nano flower and preparation method and application thereof | |
Lu et al. | Fluorescence ELISA based on CAT-regulated fluorescence quenching of CdTe QDs for sensitive detection of FB 1 | |
Wang et al. | Sensitive immunoassay of Listeria monocytogenes with highly fluorescent bioconjugated silica nanoparticles probe | |
Wang et al. | Homogeneous time-resolved FRET assay for the detection of Salmonella typhimurium using aptamer-modified NaYF 4: Ce/Tb nanoparticles and a fluorescent DNA label | |
Kim et al. | Detection of pathogenic Salmonella with nanobiosensors | |
Zheng et al. | Rapid and selective detection of Bacillus cereus in food using cDNA-based up-conversion fluorescence spectrum copy and aptamer modified magnetic separation | |
Zhang et al. | Multiplex immunoassays of plant viruses based on functionalized upconversion nanoparticles coupled with immunomagnetic separation | |
CN111139288B (en) | Fluorescent sensor for simultaneously detecting staphylococcal enterotoxins A and B based on aptamer recognition-hybrid chain reaction | |
Al-Awwal et al. | Nanoparticle immuno-fluorescent probes as a method for detection of viable E. coli O157: H7 | |
Li et al. | Review in isothermal amplification technology in food microbiological detection | |
Lian et al. | A detection method of Escherichia coli O157: H7 based on immunomagnetic separation and aptamers-gold nanoparticle probe quenching Rhodamine B’s fluorescence: Escherichia coli O157: H7 detection method based on IMS and Apt-AuNPs probe quenching Rho B’s fluorescence | |
NL2033865B1 (en) | Method for detecting salmonella typhimurium by fluorescent probe based on nitrogen and sulfur co-doped graphene quantum dots | |
NL2032665B1 (en) | Method for detecting listeria monocytogenes in cheese | |
Dudak et al. | Enumeration of immunomagnetically captured Escherichia coli in water samples using quantum dot‐labeled antibodies | |
CN110501494B (en) | Microorganism detection method based on manganese dioxide nanoflowers and fluorescent materials | |
CN114609112B (en) | Method for simply and rapidly detecting metacycline and/or doxycycline | |
US20030059839A1 (en) | Method for detecting pathogens using immunoassays | |
CN114807397A (en) | Method for detecting salmonella and drug-resistant bacteria by non-amplification time-resolved fluorescence lateral chromatography detection |